Multiple Assemblies exist for SMTL entry 3wz4
Structure of the periplasmic domain of DotI (crystal form I); X-RAY DIFFRACTION 2.20 Å

	SMTL ID 3wz4.1 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer
	SMTL ID 3wz4.2 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer
	SMTL ID 3wz4.3 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer
	SMTL ID 3wz4.4 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer
	SMTL ID 3wz4.5 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer
	SMTL ID 3wz4.6 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer
	SMTL ID 3wz4.7 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer
	SMTL ID 3wz4.8 Ligands (4R)-2-METHYLPENTANE-2,4-DIOL; (4S)-2-METHYL-2,4-PENTANEDIOL Polypeptides DotI Oligo-state monomer